Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics Revenue

In the year 2023, Spyre Therapeutics had annual revenue of $886.00K, down -61.96%.

• Revenue (ttm): $886.00K
• Revenue Growth: -61.96%
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: 30
• Market Cap: 1.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	886.00K	-1.44M	-61.96%
Dec 31, 2022	2.33M	-16.41M	-87.57%
Dec 31, 2021	18.74M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.